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Abstract
Industrial biotechnology employs the controlled use of microorganisms for the production of
synthetic chemicals or simple biomass that can further be used in a diverse array of applications
that span the pharmaceutical, chemical and nutraceutical industries. Recent advances in
metagenomics and in the incorporation of entire biosynthetic pathways into Saccharomyces
cerevisiae have greatly expanded both the fitness and the repertoire of biochemicals that can be
synthesized from this popular microorganism. Further, the availability of the S. cerevisiae entire
genome sequence allows the application of systems biology approaches for improving its enormous
biosynthetic potential. In this review, we will describe some of the efforts on using S. cerevisiae as
a cell factory for the biosynthesis of high-value natural products that belong to the families of
isoprenoids, flavonoids and long chain polyunsaturated fatty acids. As natural products are
increasingly becoming the center of attention of the pharmaceutical and nutraceutical industries,
the use of S. cerevisiae for their production is only expected to expand in the future, further allowing
the biosynthesis of novel molecular structures with unique properties.
Introduction
Microbial biosynthesis of natural products is an emerging
area of metabolic engineering and industrial biotechnol-
ogy that offers significant advantages over conventional
chemical methods or extraction from biomass. Lower
energy requirements, lower CO2 emissions, less toxic
waste in the form of solvents and metal catalysts, simpler
purification schemes, renewable feed stocks such as corn
or soybeans, and the general ability of enzymes to per-
form chiral synthesis are among the improvements to be
gained by microbial synthesis.
Within this context, almost 10 years since the publication
of its entire genome sequence [1], Saccharomyces cerevisiae,
remains the key model eukaryotic organism, with several
features that make it a useful tool for both industrial
applications and research:
1. It grows easily and adapts well in controlled fermenta-
tion environments.
2. Powerful tools for genetic engineering have been exten-
sively developed and are readily available [2-4].
3. It is nonpathogenic and has been used since ancient
times in food technology.
4. Unlike bacteria that require extensive protein engineer-
ing [5,6], yeast can readily express functional type II P450
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eukaryotic secondary metabolites [7,8].
Moreover, the availability of the entire genome sequence
has made possible the collection of comprehensive infor-
mation that allows a systems biology approach towards
strain development and optimization [9-11]. As such, S.
cerevisiae truly appears to be an ideal production platform
for important secondary metabolites, such as natural
products.
Natural products tend to encompass a wide array of small
molecules derived from both eukaryotic (plants, marine
organisms) and prokaryotic species. Their chemical struc-
ture has been fine-tuned through billions of years of evo-
lution to serve specific functions in living organisms.
Many natural products are high-value chemicals, since
only small quantities can be isolated from their native
biosynthetic organisms with the majority of them utilized
as therapeutic agents for (among others) infectious dis-
eases and cancer. The advent of genomics and metagen-
omics has allowed not only the discovery of a huge
number of new promising metabolites, but also the eluci-
dation of their biosynthetic pathways. As a result, the use
of well-characterized hosts for their efficient, large scale
production is now possible.
Since presenting the entire range of natural product bio-
synthesis in S. cerevisiae would require an extensive
amount of space, in the next few paragraphs we will only
highlight some of the most characteristic work in this area.
Isoprenoid biosynthesis
Isoprenoids (also known as terpenoids) belong to a vast
group of secondary metabolites [12] that include caroten-
oids, sterols, polyprenyl alcohols, ubiquinone (coenzyme
Q), heme A and prenylated proteins. They are of valuable
commercial interest as food colorants and antioxidants
(carotenoids), aroma and flavor enhancers (terpenes),
nutraceuticals (ubiquinone), and antiparasitic and anti-
carcinogenic compounds (taxol) [13-15].
All isoprenoids are synthesized from a universal com-
pound called isopentenyl diphosphate (IPP). The first
pathway to IPP, the mevalonic acid (MVA) pathway, was
first described by Bloch and Lynen [16,17]. In yeast, the
mevalonate pathway (Figure 1) is chiefly employed to
form ergosterol (provitamin D2) which is an essential part
of the yeast membrane and provides membrane permea-
bility and fluidity [18-21].
Some of the most important isoprenoids and their engi-
neered biosynthesis in S. cerevisiae will be further
described.
Taxol
Taxol is a complex substituted terpenoid that was first iso-
lated from the bark of Pacific yew (Taxus brevifolia). It is a
potent anticancer agent that has been approved for the
treatment of refractory ovarian and metastatic breast can-
cer. Currently, the demand for taxol greatly exceeds the
supply that can be isolated from its natural sources [22].
Very elegant total chemical syntheses of taxol have been
Biosynthesis of isoprenoids by the mevalonate pathwayF gure 1
Biosynthesis of isoprenoids by the mevalonate pathway. IPP: isopentenyl pyrophosphate; ERG10: acetoacetyl-CoA 
ligase; ERG13: 2-hydroxy-3-methylglutaryl-CoA synthase (HMG-CoA synthase); HMG1 and HMG2: 2-hydroxy-3-methylglu-
taryl-CoA reductases; ERG12: mevalonate kinase; ERG8: phosphomevalonate kinase; MVD1: diphosphomevalonate decarboxy-
lase; IDI1: isopentenyl pyrophosphate:dimethylallyl diphosphate isomerase; ERG20: farnesyl diphosphate synthase.Page 2 of 9
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of these approaches is suitable for its commercial produc-
tion. Similarly, Taxus cell cultures have yet to reach com-
mercialization due to low and unstable productivity [23].
With the partial elucidation of the taxol biosynthetic path-
way the possibility of taxadiene (a taxol biosynthetic
intermediate) biosynthesis in Escherichia coli was success-
fully demonstrated [24]. One major limitation with that
approach however is that the prokaryotic E. coli can not
functionally express the P450 enzymes that widely partic-
ipate in the taxol biosynthetic pathway. Hence, S. cerevi-
siae was chosen as an alternative, since it has been
reported that yeast was successfully employed as host for
the engineered, multi-step production of other (meval-
onate-derived) terpenoids, including steroids and carote-
noids [23].
Recently, partial taxol biosynthetic pathway was con-
structed in S. cerevisiae by expressing five sequential path-
way steps leading from primary isoprenoid metabolism to
the intermediate taxadien-5α-acetoxy-10β-ol (Figure 2)
[23]. The Taxus cuspidate genes the yeast host expressed
included geranylgeranyl disphosphate synthase (GGPPS),
taxadiene synthase (TS), cytochrome P450 taxadiene 5α-
hydroxylase (TYH5a), taxadienol 5α-O-acetyl transferase
(TAT) and taxoid 10β-hydroxylase (THY10b). The recom-
binant strain produced taxadiene at 1.0 mg/L while taxad-
ien-5α-ol was produced in very small amounts (~25 µg/
L). These results suggest that the first two enzymes
(GGPPS and TS) cooperated well with each other and that
the metabolic flux was reduced at the 5α-hydroxylation
step, which is catalyzed by a cytochrome P450 hydroxy-
lase [23]. It is anticipated that overexpressing Taxus P450
oxygenases with their corresponding P450 reductases in
Taxol biosynthesis pathwayFigure 2
Taxol biosynthesis pathway. GGPPS: Genranylgenranyl diphosphate synthase; TS: taxadiene synthase; TYHa: taxadiene 5α-
hydroxylase; TAT: taxa-4(20), 11(12)-dien-5a-ol-O-acetyltransferase; TYHb: taxane 10β-hydroxylase; TBT: taxane 2a-O-ben-
zoyltransferase; DBAT: 10-deacetyl baccatin III-O-acetyltransferase. PAM: phenyalanine aminomutase. Multiple arrows indicate 
several as of yet undefined steps. Red text indicates a cytochrome P450 enzyme.Page 3 of 9
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amounts [25].
Although the metabolic engineering of taxol biosynthesis
in yeast has only begun, the application of new protein
engineering techniques to improve rate-controlling
enzymes appears promising. As a result, S. cerevisiae
recombinant strains not only provide a new approach for
taxol production, but also create platforms that allow the
synthesis of taxol analogues and other rare taxoids for
clinical evaluation [15].
Carotenoids
Carotenoids are a subfamily of isoprenoids that are the
most widely distributed yellow, orange and red natural
pigments synthesized in bacteria, algae, fungi [26]. Com-
mercially carotenoids such as β-carotene and astaxanthin
are used as food colorants, animal feed supplements and
for nutritional and cosmetic purposes. More recently, car-
otenoids have received attention for their significant anti-
oxidant activities and for playing an important role in
inhibiting the onset of chronic diseases [27-30]. The
majority of the 600 known structures of carotenoids are
C40-carotenoids while a few bacterial carotenoids exist
with 30, 45 or 50 carbon atoms (Figure 3).
Carotenoid pathways have been successfully introduced
into noncarotenogenic microbes such as E. coli and S. cer-
evisiae [31-35]. Since S. cerevisiae produces ergosterol as its
principal isoprenoid from farnesyl diphosphate (FPP), it
would be possible to redirect the flux of FPP away from
ergosterol into genranylgenranyl diphosphate (GGPP)
and subsequent carotenoids. Indeed, the insertion of a
plasmid containing Erwinia uredovora GGPP synthase
(crtE), phytoene synthase (crtB) and phytoene desaturase
(crtI) genes under the control of various S. cerevisiae pro-
moters allowed S. cerevisiae to produce lycopene (113 µg/
g dry weight) [35]. In addition, S. cerevisiae harboring a
plasmid containing the additional E. uredovora lycopene
cyclase (crtY) gene resulted in the production of β-caro-
tene (103 µg/g dry weight) [35].
Sterols
Sterols are important for the physiology of eukaryotic
organisms as they form part of the cellular membrane
where they modulate their fluidity and function and par-
ticipate as secondary messengers in developmental signal-
ing [36]. In yeast, ergosterol is the main sterol and is
analogous to cholesterol in mammalian cells [19]. Ergos-
terol is also an economically important metabolite, as it is
the precursor for the production of vitamin D2. The com-
plex production of sterols in yeast is tightly regulated at
multiple levels. One of the major bottlenecks is the reac-
tion catalyzed by HMG-CoA (Figure 1). Overexpression of
a truncated Hmg1p led to a 40-fold increase of HMG-CoA
activity and resulted in an increased accumulation of
squalene, an intermediate towards ergosterol, of up to
5.5% of dry matter [37]. However, there was little effect
on the overall ergosterol production, suggesting addi-
tional regulation further down the pathway to ergosterol.
More recently, overexpression of the post-squalene genes
led to the discovery of two additional bottlenecks in the
pathway, namely squalene epoxidase (Erg1p) and sterol-
14alpha-demethylase (Erg11p). Overexpression of Erg1p,
Erg11p and a truncated Hmg1p led to a three-fold
increase of sterol content over the wild-type [38]. How-
ever, 90% of the sterol content was esterfied sterol inter-
mediates and not ergosterol. Obviously, further
regulatory mechanisms are at play preventing the quanti-
tative accumulation of ergosterol.
Besides ergosterol, several sterol intermediates are of bio-
logical importance including methylated sterol intermedi-
ates that activate meiosis [4,4-dimethyl-5alpha-cholesta-
8,14,24-trienol (FF-MAS) and 4,4-dimethyl-5alpha-
cholesta-8,24-dienol (T-MAS)] [39]. FF-MAS is the sub-
Carotenoid biosynthesis pathwayFigur  3
Carotenoid biosynthesis pathway. IPP: Isopentyl pyro-
phosphate; crtE: geranylgenranyl diphosphate synthase; crtB: 
phytoene synthase; crtI: phytoene desaturase; crtZ: β-caro-
tene hydroxylase; crtX: zeaxanthin glucosylase; crtM: dehy-
drosqualene synthase; crtN: dehydrosqualene desaturase; 
crtEb: lycopene elongase; crtYe/Yf: heterodimeric deca-
prenoxanthin synthase.Page 4 of 9
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While supplying exogenous ergosterol or cholesterol,
engineered strains with abolished heme biosynthesis and
deleted ERG25 gene accumulated T-MAS (1.3 mg/L) while
deleting both ERG24 and ERG25 genes accumulated FF-
MAS (5.4 mg/L) [40]. Zymosterol is another intermediate
of interest as it is the precursor of cholesterol lowering
substances. By deleting sterol transmethylase (ERG6) and
8-carbon sterol isomerase (ERG2), zymosterol accumu-
lated as the major sterol [41].
Strains able to produce sterols not native to yeast have
also been engineered. For example, a single mutation of
∆24(25)- to ∆24(28)-sterol methyl transferase (SMT) enzyme
from S. cerevisiae resulted in a protein able to synthesize
mono- and bis-C24-alkylated side chains of several
∆24(25)- and ∆24(28)-sterols [42]. Also, several 24-ethyl ster-
ols and 24-ethylidene sterols were produced in engi-
neered S. cerevisiae carrying a sterol 24-methyltransferase
gene from the Arabidopsis thaliana [43].
Long chain Polyunsaturated Fatty Acids (PUFA) 
biosynthesis
PUFAs are fatty acids of 16 or more carbon long chains
with two or more double bonds (Figure 4). Normal cellu-
lar function is dependent upon PUFAs as they are signal-
ing molecules and regulators of membrane fluidity [44].
In general, fatty acids can be synthesized endogenously;
however, PUFAs are necessary part of a diet for normal
growth and development because mammals are incapable
of synthesizing the essential linoleic acid (18:2ω6) [45],
and ω-3 and ω-6 fatty acids. Diets rich in PUFAs were
shown in studies to protect infants from cardiovascular
disease, and were beneficial for the development of retina
and brain functions [44,46].
PUFAs are commercially obtained primarily from seeds,
marine animals, microalgae and microheterotrophs. Over
the past few years, progress has been made in engineering
S. cerevisiae for fatty acid production. More specifically, in
S. cerevisiae, only saturated (mainly 16:0 and 18:0) and
mono-saturated (18:1ω9) fatty acids, are synthesized de
novo [47,48]. Formation of PUFAs requires the expression
of heterogeneous genes to introduce additional double
bonds (eg. ∆6-, ∆12-desaturases) and produce enzymes for
chain elongation (elongases) [18,49].
A number of desaturases from a variety of sources have
been discovered and functionally expressed in S. cerevisiae
to produce PUFAs. For example, expression of the ∆6-
desaturase from Mucor rouxii in yeast resulted in an accu-
mulation of γ-linolenic acid (18:3ω6) as 7.1% of the total
fatty acids when fed with linoleic acid (18:2ω6) [50].
Introducing ∆12-desaturases from various sources allows
for the accumulation of linoleic acid (18:2) and hexadec-
adienoic acid (16:2) fatty acids [51-55]. Co-expression of
both a ∆6-desaturase and a ∆12-desaturase from M. alpine
resulted in endogenous γ-linolenic acid (18:3ω6) as high
as 8% of total fatty acid content [56].
The range and length of PUFAs synthesized in yeast have
increased with the expression of various higher-eukaryote
genes. For example in yeast, arachidonic acid and eicosap-
entaenoic acid can be produced by coexpression of ∆5-
and ∆6-desaturases with a ∆6-elongase in the presence of
exogenously supplied linoleic acid and linolenic acid,
respectfully [57,58]. A desaturase from zebrafish (Danio
rerio) displayed both ∆5 and ∆6-desaturase activity
expressed in S. cerevisiae by converting linoleic acid
(18:2ω6) and α-linolenic acid (18:3ω3) into their respec-
tive ∆6-desaturase products, γ-linolenic acid (18:3ω6) and
stearidonic acid (18:4ω3) and by converting di-homo-γ-
linoleic acid (20:3ω6) and eicosatetraenoic acid (20:4ω3)
to their ∆5-desaturase products, arachionic acid (20:4ω6)
and eicosapentaenoic acid (20:5ω3) [59]. The cDNAs
encoding desaturase and elongase enzymes from various
marine and fresh water fish, a primary source of fatty acids
continue to be characterized [60,61].
Flavonoid biosynthesis
Flavonoids are a diverse group of plant secondary metab-
olites that contain a 15-carbon phenylpropanoid core,
which is extensively modified by rearrangement, alkyla-
tion, oxidation and glycosylation [62]. These fascinating
compounds possess extraordinary antioxidant activity
and they also exhibit estrogenic, antiviral, antibacterial
and anti-cancer activities [63].
Metabolic pathways of ω3 and ω6 fatty acidsFigure 4
Metabolic pathways of ω3 and ω6 fatty acids.Page 5 of 9
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lated significant research toward the elucidation of their
biosynthetic networks (Figure 5), as well as the develop-
ment of production platforms using well-characterized
hosts, such as E. coli and S. cerevisiae [64]. The ability of
yeast to express type II P450 hydroxylases, many of which
are involved in flavonoid biosynthesis, makes it an attrac-
tive production platform, even though a recent report has
demonstrated the functional expression of one such
enzyme in E. coli [65]. Ro and Douglas [66] were the first
to connect the two initial enzymes involved in phenylpro-
panoid pathway, namely phenylalanine ammonia lyase
(PAL) and cinnamate 4-hydroxylase (C4H) in S. cerevisiae
together with a cytochrome P450 reductase. The carbon
flux through the multienzyme system from phenylalanine
to p-coumaric acid in yeast was evaluated in their study.
Later, two independent studies demonstrated the biosyn-
thesis of flavanones, the common precursors of the vast
majority of flavonoids, in S. cerevisiae. The first study by
Jiang et al. [67] described the production of monohydrox-
ylated naringenin and unhydroxylated pinocembrin at
levels of 7 mg/L and 0.8 mg/L respectively. The second
study by Yan et al. [68] reported the biosynthesis of fla-
vanones in S. cerevisiae by constructing a gene cluster that
included C4H from A. thaliana, 4cL-2 from parsley, and
CHI-A (encoding for chalcone isomerase) and chs from
petunia. The recombinant S. cerevisiae strain was fed with
phenylpropanoid acids and produced naringenin (28.3
mg/L), pinocembrin (16.3 mg/L) and the trihydroxylated
flavanone eriodictyol (6.5 mg/L). In a continuation of the
previous work, Leonard et al demonstrated the biosynthe-
sis of the flavone molecules apigenin, luteolin and chrysin
by exploring the expression of a soluble flavone synthase
I (FSI) and a membrane bound flavone synthase II (FSII)
in yeast cells. The effect of the yeast P450 reductase over-
expression on flavone biosynthesis was also investigated
[8]. Recently, Ralston et al. [69] reported the partial recon-
struction of isoflavonoid biosynthesis in S. cerevisiae by
using different types of CHI and an isoflavone synthase
(IFS) from soybean (Glycine max).
With the rapid unraveling of the flavonoid biosynthetic
pathways a wide array of flavonoid compounds, natural
and unnatural, is expected to be produced from S. cerevi-
siae in the near future. In addition, the natural coloration
of some of the flavonoid molecules (anthocyanins) opens
up the possibility of using directed evolution for protein
activity fine tuning and thus further improvement of the
overall productivity [64].
Conclusion
Ever since the era of recombinant DNA technology for
natural product biosynthesis emerged [70], S. cerevisiae
has remained the production platform of choice for many
fine chemicals, including natural products. The rapid elu-
cidation of biosynthetic pathways made possible through
advanced genomic tools, has made natural product again
the molecules of choice for drug development. Indeed,
half of the drugs currently in clinical use are natural prod-
ucts and it is expected that the market size of biotech-
derived small molecules will exceed 100 billion US$ in
2010 and 400 billion US$ in 2030 [71,72]. As such, we
believe that S. cerevisiae will not only remain the cell fac-
tory of choice but that the application of powerful systems
Flavonoid biosynthesis pathwayigure 5
Flavonoid biosynthesis pathway. PAL: Phenylalanine 
ammonia-lyase; C4H: cinnamate-4-hydroxylase; 4CL: 4-cou-
maroyl:CoA-ligase; CHS: chalcone synthase; CHI: chalcone 
isomerase; FSI: flavone synthase; FSII: cytochrome P450 fla-
vone synthase; IFS: cytochrome P450 isoflavone synthase; 
FHT: flavanone 3β-hydroxylase; DFR: dihydroflavonol 4-
reductase; LAR: leucoanthocyanidin synthase; ANS: anthocy-
anidin synthase; 3GT: UDPG-flavonoid 3-O-glucosyl trans-
ferase. Red text indicates cytochrome P450 enzymes.Page 6 of 9
(page number not for citation purposes)





JAC: Contributing author and designer of all figures.
References
1. Goffeau A, Barrell BG, Bussey H, Davis RW, Dujon B, Feldmann H,
Galibert F, Hoheisel JD, Jacq C, Johnston M, Louis EJ, Mewes HW,
Murakami Y, Philippsen P, Tettelin H, Oliver SG: Life with 6000
genes.  Science 1996, 274(5287):546-&.
2. Giaever G, Chu AM, Ni L, Connelly C, Riles L, Veronneau S, Dow S,
Lucau-Danila A, Anderson K, Andre B, Arkin AP, Astromoff A, El-
Bakkoury M, Bangham R, Benito R, Brachat S, Campanaro S, Curtiss
M, Davis K, Deutschbauer A, Entian KD, Flaherty P, Foury F, Garfinkel
DJ, Gerstein M, Gotte D, Guldener U, Hegemann JH, Hempel S, Her-
man Z, Jaramillo DF, Kelly DE, Kelly SL, Kotter P, LaBonte D, Lamb
DC, Lan N, Liang H, Liao H, Liu L, Luo C, Lussier M, Mao R, Menard
P, Ooi SL, Revuelta JL, Roberts CJ, Rose M, Ross-Macdonald P, Sche-
rens B, Schimmack G, Shafer B, Shoemaker DD, Sookhai-Mahadeo S,
Storms RK, Strathern JN, Valle G, Voet M, Volckaert G, Wang CY,
Ward TR, Wilhelmy J, Winzeler EA, Yang Y, Yen G, Youngman E, Yu
K, Bussey H, Boeke JD, Snyder M, Philippsen P, Davis RW, Johnston
M: Functional profiling of the Saccharomyces cerevisiae
genome.  Nature 2002, 418(6896):387-391.
3. Mnaimneh S, Davierwala AP, Haynes J, Moffat J, Peng WT, Zhang W,
Yang X, Pootoolal J, Chua G, Lopez A, Trochesset M, Morse D, Kro-
gan NJ, Hiley SL, Li Z, Morris Q, Grigull J, Mitsakakis N, Roberts CJ,
Greenblatt JF, Boone C, Kaiser CA, Andrews BJ, Hughes TR: Explo-
ration of essential gene functions via titratable promoter
alleles.  Cell 2004, 118(1):31-44.
4. Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K,
Andre B, Bangham R, Benito R, Boeke JD, Bussey H, Chu AM, Con-
nelly C, Davis K, Dietrich F, Dow SW, El Bakkoury M, Foury F, Friend
SH, Gentalen E, Giaever G, Hegemann JH, Jones T, Laub M, Liao H,
Liebundguth N, Lockhart DJ, Lucau-Danila A, Lussier M, M'Rabet N,
Menard P, Mittmann M, Pai C, Rebischung C, Revuelta JL, Riles L, Rob-
erts CJ, Ross-MacDonald P, Scherens B, Snyder M, Sookhai-Mahadeo
S, Storms RK, Veronneau S, Voet M, Volckaert G, Ward TR, Wysocki
R, Yen GS, Yu K, Zimmermann K, Philippsen P, Johnston M, Davis
RW: Functional characterization of the S. cerevisiae genome
by gene deletion and parallel analysis.  Science 1999,
285(5429):901-906.
5. Hotze M, Schroder G, Schroder J: Cinnamate 4-hydroxylase
from Catharanthus roseus, and a strategy for the functional
expression of plant cytochrome P-450 proteins as transla-
tional fusions with P-450 reductase in Escherichia coli.  Febs
Letters 1995, 374(3):345-350.
6. Sieber V, Martinez CA, Arnold FH: Libraries of hybrid proteins
from distantly related sequences.  Nature Biotechnology 2001,
19(5):456-460.
7. Pompon D, Louerat B, Bronine A, Urban P: Yeast expression of
animal and plant P450s in optimized redox environments.
Cytochrome P450, Pt B 1996, 272:51-64.
8. Leonard E, Yan YJ, Lim KH, Koffas MAG: Investigation of two dis-
tinct flavone synthases for plant-specific flavone biosynthesis
in Saccharomyces cerevisiae.  Applied and Environmental Microbiol-
ogy 2005, 71(12):8241-8248.
9. Forster J, Famili I, Fu P, Palsson BO, Nielsen J: Genome-scale
reconstruction of the Saccharomyces cerevisiae metabolic
network.  Genome Research 2003, 13(2):244-253.
10. Patil KR, Akesson M, Nielsen J: Use of genome-scale microbial
models for metabolic engineering.  Current Opinion in Biotechnol-
ogy 2004, 15(1):64-69.
11. Daran-Lapujade P, Jansen MLA, Daran JM, van Gulik W, de Winde JH,
Pronk JT: Role of transcriptional regulation in controlling
fluxes in central carbon metabolism of Saccharomyces cere-
visiae - A chemostat culture study.  J Biol Chem J Biol Chem 2004,
279(10):9125-9138.
12. Sacchettini JC, Poulter CD: Creating isoprenoid diversity.  Science
1997, 277(5333):1788-1789.
13. Watts KT, Mijts BN, Schmidt-Dannert C: Current and emerging
approaches for natural product biosynthesis in microbial
cells.  Advanced Synthesis & Catalysis 2005, 347(7-8):927-940.
14. Haynes RK, Krishna S: Artemisinins: activities and actions.
Microbes and Infection 2004, 6(14):1339-1346.
15. Jennewein S, Croteau R: Taxol: biosynthesis, molecular genet-
ics, and biotechnological applications.  Applied Microbiology and
Biotechnology 2001, 57(1-2):13-19.
16. Katsuki HBK: Studies on the biosynthesis of ergosterol in
yeast. Formation of methylated internediates.  Journal of Biolog-
ical Chemistry 1967, 242:222-227.
17. Lynen F: Biosynthetic pathways from acetate to natural prod-
ucts.  Pure and Applied Chemistry 1967, 14(1):137-167.
18. Veen M, Lang C: Production of lipid compounds in the yeast
Saccharomyces cerevisiae.  Applied Microbiology and Biotechnology
2004, 63(6):635-646.
19. Bloch KE: Sterol structure and membrane function.  CRC Criti-
cal Reviews in Biochemistry 1983, 14(1):47-92.
20. Parks LW, Casey WM: Physiological implications of sterol bio-
synthesis in yeast.  Annual Review of Microbiology 1995, 49:95-116.
21. Parks LW, Smith SJ, Crowley JH: Biochemical and physiological
effects of sterol alterations in yeast - A review.  Lipids 1995,
30(3):227-230.
22. Hezari M, Lewis NG, Croteau R: Purification and characteriza-
tion of taxa-4(5),11(12)-diene synthase from Pacific Yew
(Taxus brevifolia) that catalyzes the first committed step of
taxol biosynthesis.  Archives of Biochemistry and Biophysics 1995,
322(2):437-444.
23. Dejong JM, Liu Y, Bollon AP, Long RM, Jennewein S, Williams D, Cro-
teau RB: Genetic engineering of taxol biosynthetic genes in
Saccharomyces cerevisiae.  Biotechnol Bioeng 2006,
93(2):212-224.
24. Yang CS, Landau JM, Huang MT, Newmark HL: Inhibition of car-
cinogenesis by dietary polyphenolic compounds.  Annual
Review of Nutrition 2001, 21:381-406.
25. Jennewein S, Park H, DeJong JM, Long RM, Bollon AP, Croteau RB:
Coexpression in yeast of Taxus cytochrome P450 reductase
with cytochrome P450 oxygenases involved in Taxol biosyn-
thesis.  Biotechnol Bioeng 2005, 89(5):588-598.
26. Goodwin TW, Britton G: Distribution and analysis of caroten-
oids.  In Plant Pigments Edited by: Goodwin TW. London , Academic
Press; 1988:61-132. 
27. Bertram JS: Carotenoids and gene regulation.  Nutrition Reviews
1999, 57(6):182-191.
28. Edge R, McGarvey DJ, Truscott TG: The carotenoids as anti-oxi-
dants - a review.  J Photoch Photobio B J Photoch Photobio B 1997,
41(3):189-200.
29. Giuliano A: Cancer chemoprevention - Part 1: Retinoids and
carotenoids and other classic antioxidants - The Singh/Lipp-
man article reviewed.  Oncology-New York 1998,
12(11):1659-1660.
30. Smith TAD: Carotenoids and cancer: prevention and potential
therapy.  Brit J Biomed Sci Brit J Biomed Sci 1998, 55(4):268-275.
31. Misawa N, Nakagawa M, Kobayashi K, Yamano S, Izawa Y, Nakamura
K, Harashima K: Elucidation of the Erwinia uredovora carote-
noid biosynthetic pathway by functional analysis of gene
products expressed in Escherichia coli.  Journal of Bacteriology
1990, 172(12):6704-6712.
32. Misawa N, Yamano S, Ikenaga H: Production of beta-carotene in
Zymomonas mobilis and Agrobacterium tumefaciens by
introduction of the biosynthesis genes from Erwinia ure-
dovora.  Applied and Environmental Microbiology 1991,
57(6):1847-1849.
33. Misawa N, Yamano S, Linden H, de Felipe MR, Lucas M, Ikenaga H,
Sandmann G: Functional expression of the Erwinia uredovora
carotenoid biosynthesis gene Crtl in transgenic plants show-
ing an increase of beta-carotene biosynthesis activity and
resistance to the bleaching herbicide Norflurazon.  Plant Jour-
nal 1993, 4(5):833-840.
34. Ausich RL: Production of carotenoids by recombinant-DNA
technology.  Pure Appl Chem 1994, 66(5):1057-1062.Page 7 of 9
(page number not for citation purposes)
Microbial Cell Factories 2006, 5:20 http://www.microbialcellfactories.com/content/5/1/2035. Yamano S, Ishii T, Nakagawa M, Ikenaga H, Misawa N: Metabolic
engineering for production of beta-carotene and lycopene in
Saccharomyces cerevisiae.  Biosci Biotechnol Biochem 1994,
58(6):1112-1114.
36. Mansour MP, Volkman JK, Blackburn SI: The effect of growth
phase on the lipid class, fatty acid and sterol composition in
the marine dinoflagellate, Gymnodinium sp in batch culture.
Phytochemistry 2003, 63(2):145-153.
37. Polakowski T, Stahl U, Lang C: Overexpression of a cytosolic
hydroxymethylglutaryl-CoA reductase leads to squalene
accumulation in yeast.  Appl Microbiol Biotechnol 1998,
49(1):66-71.
38. Veen M, Stahl U, Lang C: Combined overexpression of genes of
the ergosterol biosynthetic pathway leads to accumulation
of sterols in Saccharomyces cerevisiae.  Fems Yeast Research
2003, 4(1):87-95.
39. Byskov AG, Andersen CY, Leonardsen L, Baltsen M: Meiosis acti-
vating sterols (MAS) and fertility in mammals and man.  J Exp
Zool 1999, 285(3):237-242.
40. Xu R, Wilson WK, Matsuda SPT: Production of melosis-activat-
ing sterols from metabolically engineered yeast.  J Am Chem
Soc J Am Chem Soc 2002, 124(6):918-919.
41. Heidepriem RW, Livant PD, Parish EJ, Barbuch RJ, Broaddus MG,
Bard M: A simple method for the isolation of zymosterol from
a sterol mutant of Saccharomyces cerevisiae.  J Steroid Biochem
J Steroid Biochem 1992, 43(7):741-743.
42. Nes WD, McCourt BS, Marshall JA, Ma JZ, Dennis AL, Lopez M, Li
HX, He L: Site-directed mutagenesis of the sterol methyl
transferase active site from Saccharomyces cerevisiae
results in formation of novel 24-ethyl sterols.  J Org Chem J Org
Chem 1999, 64(5):1535-1542.
43. Husselstein T, Gachotte D, Desprez T, Bard M, Benveniste P: Trans-
formation of Saccharomyces cerevisiae with a cDNA encod-
ing a sterol C-methyltransferase from Arabidopsis thaliana
results in the synthesis of 24-ethyl sterols.  FEBS Lett 1996,
381(1-2):87-92.
44. von Schacky C, Dyerberg J: Omega 3 fatty acids. From eskimos
to clinical cardiology - What took us so long?  World Rev Nutr
2001, 88:90-99.
45. Broun P, Gettner S, Somerville C: Genetic engineering of plant
lipids.  Annual Review of Nutrition 1999, 19:197-216.
46. Damsgaard CT, Schack-Nielsen L, Michaelsen KF, Fruekilde MB, Hels
O, Lauritzen L: Fish oil affects blood pressure and the plasma
lipid profile in healthy Danish infants.  J Nutr 2006,
136(1):94-99.
47. Daum G, Vance JE: Import of lipids into mitochondria.  Progress
in Lipid Research 1997, 36(2-3):103-130.
48. Martin CE, Oh CS, Kandasamy P, Chellapa R, Vemula M: Yeast
desaturases.  Biochem Soc T Biochem Soc T 2002, 30:1080-1082.
49. Dyal SD, Narine SS: Implications for the use of Mortierella fungi
in the industrial production of essential fatty acids.  Food Res
Int Food Res Int 2005, 38(4):445-467.
50. Laoteng K, Mannontarat R, Tanticharoen M, Cheevadhanarak S: ∆6-
Desaturase of Mucor rouxii with high similarity to plant ∆6-
desaturase and its heterologous expression in Saccharomy-
ces cerevisiae.  Biochem Bioph Res Co Biochem Bioph Res Co 2000,
279(1):17-22.
51. Covello PS, Reed DW: Functional expression of the extraplas-
tidial Arabidopsis thaliana oleate desaturase gene (FAD2) in
Saccharomyces cerevisiae.  Plant Physiology 1996,
111(1):223-226.
52. Sakuradani E, Kobayashi M, Ashikari T, Shimizu S: Identification of
∆12-fatty acid desaturase from arachidonic acid-producing
Mortierella fungus by heterologous expression in the yeast
Saccharomyces cerevisiae and the fungus Aspergillus
oryzae.  Eur J Biochem Eur J Biochem 1999, 261(3):812-820.
53. Kajiwara S, Shirai A, Fujii T, Toguri T, Nakamura K, Ohtaguchi K: Pol-
yunsaturated fatty acid biosynthesis in Saccharomyces cere-
visiae: Expression of ethanol tolerance and the FAD2 gene
from Arabidopsis thaliana.  Applied and Environmental Microbiology
1996, 62(12):4309-4313.
54. Peyou-Ndi MM, Watts JL, Browse J: Identification and character-
ization of an animal ∆12 fatty acid desaturase gene by heter-
ologous expression in Saccharomyces cerevisiae.  Arch
Biochem Biophys 2000, 376(2):399-408.
55. Suga K, Honjoh K, Furuya N, Shimizu H, Nishi K, Shinohara F, Hira-
baru Y, Maruyama I, Miyamoto T, Hatano S, Iio M: Two low-tem-
perature-inducible Chlorella genes for ∆12 and ω-3 fatty acid
desaturase (FAD): Isolation of ∆12 and ω-3 FAD cDNA
clones, expression of ∆12 fad in Saccharomyces cerevisiae,
and expression of ω-3 fad in Nicotiana tabacum.  Bioscience Bio-
technology and Biochemistry 2002, 66(6):1314-1327.
56. Huang YS, Chaudhary S, Thurmond JM, Bobik EG, Yuan L, Chan GM,
Kirchner SJ, Mukerji P, Knutzon DS: Cloning of ∆12-and ∆6-desat-
urases from Mortierella alpina and recombinant production
of γ-linolenic acid in Saccharomyces cerevisiae.  Lipids 1999,
34(7):649-659.
57. Beaudoin F, Michaelson LV, Hey SJ, Lewis MJ, Shewry PR, Sayanova O,
Napier JA: Heterologous reconstitution in yeast of the polyun-
saturated fatty acid biosynthetic pathway.  Proc Natl Acad Sci U
S A 2000, 97(12):6421-6426.
58. Domergue F, Abbadi A, Ott C, Zank TK, Zahringer U, Heinz E: Acyl
carriers used as substrates by the desaturases and elongases
involved in very long-chain polyunsaturated fatty acids bio-
synthesis reconstituted in yeast.  J Biol Chem 2003,
278(37):35115-35126.
59. Hastings N, Agaba M, Tocher DR, Leaver MJ, Dick JR, Sargent JR,
Teale AJ: A vertebrate fatty acid desaturase with ∆5 and ∆6
activities.  P Natl Acad Sci USA P Natl Acad Sci USA 2001,
98(25):14304-14309.
60. Agaba M, Tocher DR, Dickson CA, Dick JR, Teale AJ: Zebrafish
cDNA encoding multifunctional fatty acid elongase involved
in production of eicosapentaenoic (20 : 5n-3) and docosahex-
aenoic (22 : 6n-3) acids.  Marine Biotechnology 2004, 6(3):251-261.
61. Agaba MK, Tocher DR, Zheng XZ, Dickson CA, Dick JR, Teale AJ:
Cloning and functional characterisation of polyunsaturated
fatty acid elongases of marine and freshwater teleost fish.
Comp Biochem Phys B Comp Biochem Phys B 2005, 142(3):342-352.
62. Turnbull JJ, Nakajima J, Welford RWD, Yamazaki M, Saito K, Schofield
CJ: Mechanistic studies on three 2-oxoglutarate-dependent
oxygenases of flavonoid biosynthesis - Anthocyanidin syn-
thase, flavonol synthase, and flavanone 3 β-hydroxylase.  J of
Biol Chem 2004, 279(2):1206-1216.
63. Forkmann G, Martens S: Metabolic engineering and applications
of flavonoids.  Current Opinion in Biotechnology 2001, 12(2):155-160.
64. Yan Y, Chemler J, Huang L, Martens S, Koffas MA: Metabolic engi-
neering of anthocyanin biosynthesis in Escherichia coli.  Appl
Environ Microbiol 2005, 71(7):3617-3623.
65. Leonard E, Yan Y, Koffas MA: Functional expression of a P450
flavonoid hydroxylase for the biosynthesis of plant-specific
hydroxylated flavonols in Escherichia coli.  Metab Eng 2006,
8(2):172-181.
66. Ro DK, Douglas CJ: Reconstitution of the entry point of plant
phenylpropanoid metabolism in yeast (Saccharomyces cere-
visiae) - Implications for control of metabolic flux into the
phenylpropanoid pathway.  J of Biol Chem 2004,
279(4):2600-2607.
67. Jiang HX, Wood KV, Morgan JA: Metabolic engineering of the
phenylpropanoid pathway in Saccharomyces cerevisiae.
Applied and Environmental Microbiology 2005, 71(6):2962-2969.
68. Yan Y, Kohli A, Koffas MA: Biosynthesis of natural flavanones in
Saccharomyces cerevisiae.  Applied and Environmental Microbiology
2005, 71(9):5610-5613.
69. Ralston L, Subramanian S, Matsuno M, Yu O: Partial reconstruc-
tion of flavonoid and isoflavonoid biosynthesis in yeast using
soybean type I and type II chalcone isomerases.  Plant Physiology
2005, 137(4):1375-1388.
70. Hopwood DA, Malpartida F, Kieser HM, Ikeda H, Duncan J, Fujii I,
Rudd BA, Floss HG, Omura S: Production of 'hybrid' antibiotics
by genetic engineering.  Nature 1985, 314(6012):642-644.
71. Maury J, Asadollahi MA, Moller K, Clark A, Nielsen J: Microbial iso-
prenoid production: An example of green chemistry through
metabolic engineering.  Biotechnology for the Future 2005,
100:19-51.
72. Paterson I, Anderson EA: Chemistry. The renaissance of natural
products as drug candidates.  Science 2005, 310(5747):451-453.
73. Koffas M, Stephanopoulos G: Strain improvement by metabolic
engineering: lysine production as a case study for systems
biology.  Current Opinion in Biotechnology 2005, 16(3):361-366.
74. Raab RM, Tyo K, Stephanopoulos G: Metabolic engineering.  Adv
Biochem Eng Biotechnol 2005, 100:1-17.Page 8 of 9
(page number not for citation purposes)
Microbial Cell Factories 2006, 5:20 http://www.microbialcellfactories.com/content/5/1/20Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
75. Bro C, Regenberg B, Forster J, Nielsen J: In silico aided metabolic
engineering of Saccharomyces cerevisiae for improved
bioethanol production.  Metab Eng Metab Eng 2006, 8(2):102-111.Page 9 of 9
(page number not for citation purposes)
